AN 415 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base))
Pill with imprint AN 415 is Orange, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Amneal Pharmaceuticals.
Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for AN 415
Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)
- Imprint
- AN 415
- Strength
- 8 mg (base) / 2 mg (base)
- Color
- Orange
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Amneal Pharmaceuticals
- Inactive Ingredients
-
acesulfame potassium,
citric acid anhydrous,
FD&C Yellow No. 6,
lactose monohydrate,
magnesium stearate,
mannitol,
povidone,
sodium citrate,
corn starch
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 65162-0415 | Amneal Pharmaceuticals LLC |
| 42291-0175 (Discontinued) | AvKare, Inc. |
| 00406-1924 | Mallinckrodt Inc. |
Related Images for "AN 415"
More about buprenorphine / naloxone
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (1,047)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: narcotic analgesic combinations
- Latest FDA Alerts (2)
Patient resources
- Drug Information
- Buprenorphine/naloxone Oromucosal, Sublingual (Advanced Reading)
- Buprenorphine and Naloxone Sublingual Tablets
- Buprenorphine and Naloxone Buccal Film
- Buprenorphine and Naloxone Sublingual Film (Suboxone)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.